Retraction: MiR-22 inhibition alleviates cardiac dysfunction in doxorubicin-induced cardiomyopathy by targeting the sirt1/PGC-1α pathway
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details